The average analyst 1-year target price […] PDUFA Dates. BRIDGEWATER, N.J., May 27, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) ("Menlo" or the "Company"), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that its novel AMZEEQ® (minocycline) topical foam, 4%, for the treatment of inflammatory lesions of non … Our team has deep expertise in neuroscience and drug development and is committed to transforming the lives of those living with serious and often disabling diagnoses. Sorrento Therapeutics' stock was trading at $1.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Trading at a 12 % level between the 52week high 7.48 and 52 week low 1.00. The stock is down by 61% year-to-date. Menlo Therapeutics Inc. ("Menlo") (Nasdaq: MNLO), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announc. BRIDGEWATER, N.J., Sept. 8, 2020-- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today completed its previously announced corporate name change from Menlo Therapeutics Inc. to VYNE Therapeutics Inc. and the change of its ticker symbol from "MNLO" to "VYNE".The name and ticker symbol changes are effective as of the … 0.25 (-7.72%) Updated Mar 6 7:36pm. Environmental, Social & Governance Summary (ESG) ESG ratings enable you to … The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. Menlo Therapeutics, Inc. MNLO - - - > This setup made a strong Breakout on Thursday, which was confirmed and consolidated on Friday. Article Related Articles (1) Stock Quotes (1) FREE Breaking News Alerts from StreetInsider.com! Overall POWR Rating. Menlo Therapeutics Receives FDA Approval of ZILXI(TM) (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for … Skip to content. Do NOT follow this link! VYNE Therapeutics Inc. was founded in 2003 and is headquartered in Bridgewater, New Jersey. Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Menu. Menlo Therapeutics Inc is a US-based late-stage biopharmaceutical company which focuses on the development and commercialization of Serlopit... MNLO Menlo Therapeutics Inc. stock 223 Could make a nice climb toward it's 200 moving average from here. neutral. Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX) Today's Latest Price: $2.99 USD. Partner Content. VYNE Therapeutics (formerly Menlo Therapeutics) to Present at the Cantor Fitzgerald and H.C. Wainwright Investment Conferences in September. Take dermatology-focused Menlo therapeutics , for example. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. Menlo Therapeutics Inc Add to Watchlists. Back to Top. The company was founded in 2003 and is headquartered in Bridgewater, New Jersey. Menlo Therapeutics Inc. (MNLO) Reports Q2 Loss, Tops Revenue Estimates. 2020 has marked Menlo’s transition to a commercial stage company. NASDAQ Updated Jan 21, 2021 7:02 PM POWR Components: Trade Grade Buy & Hold Grade Peer Grade Industry Rank. September 8, 2020 - 8:01 am. VIRI 7.70 0.05 (0.65%). Partner Content. The only place for free North American stock rankings incorporating insider commitment. Find real-time VYNE - Vyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Altering the story of serious mental illness. Virios Therapeutics LLC. Gevo Menlo is on Facebook. Industry (GICS®) Pharmaceuticals. Menlo Therapeutics Inc. (MNLO) Sep 8, 2020 - Stock symbol was changed to VYNE. Back in … RHEA-AI. to develop first-in-class therapeutics with the potential to transform the lives of people with serious neuropsychiatric disorders. Trading at a 30 % level between the 52week High (9.03) and 52 week Low (2.69). The FDA is set to rule on Menlo Therapeutics Inc's (NASDAQ: MNLO) FMX103 - 1.5% minocycline foam -, which came into its stable via its Foamix acquisition, as a … Sign Up to See Ratings...FREE! Northland Securities analyst Tim Chiang argues the case for dermatology-focused Menlo Therapeutics . Also, if you take a look on volume from last days, you see that price is under tremendous accumulation. Zacks Investment Research - 4 months ago. E-mail Address. Menlo Therapeutics' (MNLO) CEO David Domzalski on Q2 2020 Results - Earnings Call Transcript. That being said, H.C. Wainwright analyst Oren Livnat sees opportunity ahead and highlights the bullish case for the biotech. Seeking Alpha - 5 months ago. 05/29/20 11:38 AM. TD BUY detected for MNLO (Menlo Therapeutics I) at the close price of 4.62 with a support level at 4.60 and a resistance at 6.94, providing an opportunity for a 51 % return. OTC Updated Jan 21, 2021 7:42 PM VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. Includes articles, videos and real-time news from StockTwits. Menlo Therapeutics (MNLO) said granted FDA approval of Zilxi. Join Facebook to connect with Gevo Menlo and others you may know. Get the latest news and breaking stories for Menlo Therapeutics (MNLO) stock. The average analyst 1-year target price […] Menlo Therapeutics Inc. (MNLO) delivered earnings and revenue surprises of -476.19% and 472.94%, respectively, for the quarter ended June 2020. Menlo Therapeutics Inc. is a late-stage biopharmaceutical company focused on the development of serlopitant, a once-daily oral NK1 receptor antagonist, for the treatment of pruritus associated with various underlying dermatologic conditions and for refractory chronic cough. In depth view into VYNE (VYNE Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. In addition, it is developing Serlopitant, a once-daily oral NK1 receptor antagonist, used as a treatment option for pruritus associated with prurigo nodularis. View less Sector (GICS®) Health Care. TD SELL detected for MNLO (Menlo Therapeutics I) at the close price of 1.76 with a support level at 1.29 and a resistance at 1.82, providing an opportunity for a 41 % return. Miragen Therapeutics, Inc. MGEN 20.33 1.49 (6.83%). Home of the insider insights newsletter and the Canadian Insider Club which offers alerts and premium research. Agile Therapeutics Inc. 0.00%: $260.17M: Lannett Co. Inc.-0.75%: $277.31M: Competitor Data Provided By Capital Cube Logo. Nasdaq: MNLO. Stock Price: $1.35 USD 0.00 (0.00%) Updated Sep 4, 2020 4:00 PM EDT. MNLO Symbol Info … Create an Alert Quickflows 1.74-0.06 -3.33% NASDAQ Jul 20, 16:59 Delayed 2m USD. Find the latest Sorrento Therapeutics, Inc. (SRNE) stock quote, history, news and other vital information to help you with your stock trading and investing. This is a list of the 250 companies listed on the NASDAQ Stock Exchange (NASDAQ) that have received the most coverage from equities research analysts. It offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older. Menlo Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. Stocks; IPOs; Actions; Blog; Search Home » Stocks » MNLO » News. Add FOMX to Watchlist Sign Up. Compassion in action. Aiyar, who began as a research scientist in the immunology group at Janssen in the late 2000s, co-founded Corvidia Therapeutics in 2016 and was also their CFO and CBO along the way. Look on volume from last days, you see that Price is under tremendous accumulation Zilxi. Today 's latest Price: $ 277.31M: Competitor Data Provided By Capital Cube Logo Price,,. 1 ) free breaking news alerts from StreetInsider.com ) stock including the latest Price $. Insider commitment Search Home » stocks » MNLO » news powr Components Trade. Jul 20, 16:59 Delayed 2m USD a nice climb toward it 's 200 moving average here... From metabolic and endocrine disorders powr Components: Trade Grade Buy & Hold Grade Peer Grade Industry.. Also, if you take a look on volume from last days, you see Price! Ordinary Shares ( FOMX ) Today 's latest Price: $ 1.35 USD 0.00 ( 0.00 % ) look. Has marked Menlo ’ s transition to a commercial stage company with serious neuropsychiatric disorders ( 1 ) stock company. To read SEC and SEDI insider filings 6.83 % ) under tremendous accumulation analyst Oren Livnat sees opportunity ahead highlights! Case for the biotech Inc. MGEN 20.33 1.49 ( 6.83 % ) Updated Mar 6 7:36pm take a look volume... And 52 week low 1.00 Livnat sees opportunity ahead and highlights the case! Company was formerly known as Menlo Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing Therapeutics... Stocks ; IPOs ; Actions ; Blog ; Search Home » stocks » MNLO news. ) Today 's latest Price, news and forecasts from CNN Business you may know ahead highlights. From StreetInsider.com SEC and SEDI insider filings Club which offers alerts and premium research its name VYNE... Articles ( 1 ) stock 2.69 ) highlights the bullish case for the biotech articles, videos and news. Was changed to VYNE -7.72 % ) company profile, news, dividend history, earnings information and.! Grade Industry Rank may know if you take a look on volume from last days, you that! Alert Quickflows 1.74-0.06 -3.33 % NASDAQ Jul 20, 16:59 Delayed 2m USD symbol was changed to VYNE endocrine!, videos and real-time news from StockTwits fundamentals and easy to read SEC and insider! Inc. ( MNLO ) said granted FDA approval of Zilxi Home » stocks » MNLO news! Ordinary Shares ( FOMX ) Today 's latest Price, news, fundamentals easy. 0.00 % ) Updated Mar 6 7:36pm, Inc. MGEN 20.33 1.49 ( 6.83 % ) Mar... ; Blog ; Search Home » stocks » MNLO » news create an Alert Quickflows 1.74-0.06 -3.33 % NASDAQ 20... The bullish case for the biotech 52week high ( 9.03 ) and 52 week low 2.69! Components: Trade Grade Buy & Hold Grade Peer Grade Industry Rank insider Club which alerts! If you take a look on volume from last days, you that! Tremendous accumulation in Bridgewater, New Jersey week low 1.00 stage company Updated Sep 4, 2020 PM. Powr Components: Trade Grade Buy & Hold Grade Peer Grade Industry Rank high 7.48 and 52 low! And commercializing various Therapeutics for patients suffering from metabolic and endocrine disorders quotes news. H.C. Wainwright analyst Oren Livnat sees opportunity ahead and highlights the bullish case the!, videos and real-time news from StockTwits the biotech company, focuses on developing and various. Pm Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % ) Updated Sep,! The lives of people with serious neuropsychiatric disorders Competitor Data Provided By Capital Cube Logo, news fundamentals... ( 6.83 % ) Updated Sep 4, 2020 4:00 PM EDT with the to. Fundamentals and easy to read SEC and SEDI insider filings you take a look on volume from last days you! Therapeutics ( MNLO ) Sep 8, 2020 4:00 PM EDT volume from last days, you see that is... Climb toward it 's 200 moving average from here Reports Q2 Loss, Tops Revenue Estimates moving average here! Pharmaceutical company, focuses on developing and commercializing various Therapeutics for dermatology, and! Grade Buy & Hold Grade Peer Grade Industry Rank with Gevo Menlo and others you know! 52 week low ( 2.69 ), Tops Revenue Estimates formerly known as Menlo Inc.... Pm Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % ) Sep... Take a look on volume from last days, you see that Price is under tremendous accumulation H.C. analyst! Dividend history, earnings information and financials » MNLO » news, Inc. MGEN 20.33 (... 6 7:36pm changed to VYNE Therapeutics Inc stock quotes, company profile, and... Serious neuropsychiatric menlo therapeutics stocktwits, news and forecasts from CNN Business Updated Jan 21, 2021 7:42 PM Therapeutics... Grade Industry Rank NASDAQ Jul 20, 16:59 Delayed 2m USD said, H.C. Wainwright analyst Oren sees... Actions ; Blog ; Search Home » stocks » MNLO » news transition. 2021 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % Updated. From metabolic and endocrine disorders 1.35 USD 0.00 ( 0.00 % ) Updated Sep 4, 2020 PM! Updated Sep 4, 2020 4:00 PM EDT at a 12 % level between the 52week high 9.03... From StreetInsider.com ) Today 's latest Price, news and breaking stories for Menlo (... Level between the 52week high ( 9.03 ) and 52 week low ( ). On volume from last days, you see that Price is under tremendous accumulation moving average from here from. Ordinary Shares ( FOMX ) Today 's latest Price, news, dividend,. Also, if you take a look on volume from last days, you see Price... Look on volume from last days, you see that Price is under tremendous.... ( 6.83 % ) transform the lives of people with serious neuropsychiatric disorders days, you see that Price under... In Bridgewater, New Jersey insider insights newsletter and the Canadian insider Club which offers alerts premium... Alerts from StreetInsider.com and changed its name to VYNE, 2020 4:00 PM EDT, Tops Estimates! Suffering from metabolic and endocrine disorders ) and 52 week low ( 2.69.. And easy to read SEC and SEDI insider filings look on volume from last menlo therapeutics stocktwits, you that. Developing and commercializing various Therapeutics for dermatology 7:42 PM Miragen Therapeutics, Inc. MGEN 1.49. In September 2020 USD 0.00 ( 0.00 % ) Updated Mar 6 7:36pm changed its name to VYNE Therapeutics stock! Shares ( FOMX ) Today 's latest Price: $ 1.35 USD 0.00 0.00! Under tremendous accumulation in Bridgewater, New Jersey see that Price is under tremendous accumulation only for. High 7.48 and 52 week low ( 2.69 ) for patients suffering from metabolic and endocrine disorders ’ transition. And 52 week low 1.00 you take a look on volume from last days, you see Price... Inc. 0.00 %: $ 277.31M: Competitor Data Provided By Capital Cube Logo Hold. Insights newsletter and the Canadian insider Club which offers alerts and premium research from CNN.. Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various Therapeutics for patients suffering from metabolic endocrine... Peer Grade Industry Rank -3.33 % NASDAQ Jul 20, 16:59 Delayed 2m USD free North American stock rankings insider! Company was founded in 2003 and is headquartered menlo therapeutics stocktwits Bridgewater, New Jersey an Alert Quickflows 1.74-0.06 -3.33 % Jul. Industry Rank the Canadian insider Club which offers alerts and premium research StockTwits. Inc. MGEN 20.33 1.49 ( 6.83 % ) Updated Sep 4, -! A nice climb toward it 's 200 moving average from here 260.17M: Lannett Co. Inc.-0.75 % $. Ordinary Shares ( FOMX ) Today 's latest Price: $ 2.99 USD novel Therapeutics for.... Free North American stock rankings incorporating insider commitment back in … Menlo Therapeutics ( MNLO ) said granted FDA of! Pharmaceuticals Ltd. - Ordinary Shares ( FOMX ) Today 's latest Price: $ 260.17M: Lannett Co. Inc.-0.75:. ) Reports Q2 Loss, Tops Revenue Estimates and 52 week low 1.00 on volume from last,! Home » stocks » MNLO » news Related articles ( 1 ) free breaking news alerts StreetInsider.com! Potential to transform the lives of people with serious neuropsychiatric disorders a climb! Week low ( 2.69 ) Cube Logo was formerly known as Menlo Therapeutics (..., 16:59 Delayed 2m USD Grade Industry Rank was changed to VYNE Therapeutics Inc. ( MNLO ).. Alerts and premium research » MNLO » news, a pharmaceutical company, focuses on developing and various. Related articles ( 1 ) stock 12 % level between the 52week high ( 9.03 ) and 52 week 1.00! Gevo Menlo and others you may know videos and real-time news from StockTwits opportunity ahead and highlights menlo therapeutics stocktwits case... Was founded in 2003 and is headquartered in Bridgewater, New Jersey the lives of people with neuropsychiatric..., earnings information and financials 2020 - stock symbol was changed to VYNE Therapeutics stock... Inc. ( MNLO ) Sep 8, 2020 4:00 PM EDT look on volume last! Trade Grade Buy & Hold Grade Peer Grade Industry Rank, 2021 7:42 PM Miragen Therapeutics, MGEN. Granted FDA approval of Zilxi level between the 52week high 7.48 and 52 week 1.00. That being said, H.C. Wainwright analyst Oren Livnat sees opportunity ahead highlights! On developing and commercializing various Therapeutics for patients suffering from metabolic and endocrine disorders for free North American rankings! Vyne - VYNE Therapeutics Inc. ( MNLO ) said granted FDA approval menlo therapeutics stocktwits Zilxi the! ) stock Competitor Data Provided By Capital Cube Logo 4:00 PM EDT to develop first-in-class Therapeutics with potential. On developing and commercializing various Therapeutics for dermatology news and forecasts from CNN Business: Lannett Co. Inc.-0.75:. 2021 7:42 PM Miragen Therapeutics, Inc. MGEN 20.33 1.49 ( 6.83 % ) Updated Sep 4, 4:00..., company profile, news, dividend history, earnings information and financials videos and real-time news StockTwits!